Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across multiple tumor types...
The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award!JACKSON CENTER, Pa., March 17, 2025 (GLOBE NEWSWIRE) --...
- Dosed the first patient in the Phase 2 Elumina trial of VLS-01 (buccal film DMT) for patients with treatment-resistant...
New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with Disopyramideand Longer-Term Effect on...
The Annual Meeting is the foremost educational and scientific event for gynecologic oncologistsStenoparib has shown clinical benefit in...
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform...
SAN DIEGO and TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:...
Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the...
–Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and...
ANN ARBOR, Mich., March 17, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a...
sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved,...
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry...
EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test AccuracyMISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE...
DeepView® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history,...
– Gino Santini Appointed as Chairman of the Board, Michael Heffernan, Founder and Chairman and Gwen A. Melincoff, Board...
Vancouver, British Columbia--(Newsfile Corp. - March 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD)...
Toronto, Ontario--(Newsfile Corp. - March 17, 2025) - Neural Therapeutics Inc. (CSE: NURL) ("Neural" or the "Company"), an ethnobotanical drug...
GUANGZHOU, China, March 17, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions,...
DES MOINES, Iowa, March 17, 2025 /PRNewswire/ -- Biospace.com, the leading life science news and careers site, is celebrating its...
BENGALURU, India , March 17, 2025 /PRNewswire/ -- 4baseCare, a leader in precision oncology, has achieved a major milestone with CAP...
